Triamcinolone Hexacetonide Injection Shortage
Last Updated: April 6, 2025
Status: Current
Products Affected - Description
-
- Hexatrione injection, Medexus Pharma, 20 mg/mL, 2 mL ampule, 1 count, NDC 59137-0570-01
Reason for the Shortage
-
- Sandoz discontinued Aristospan in September 2020.
Available Products
-
- There are no presentations available
Estimated Resupply Dates
-
- Medexus in conjunction with FDA has had initiated a temporary importation of Triamcinolone Hexacetonide (Hexatrione 2%) injectable suspension 20 mg/mL 2 mL ampules (NDC 59137-0570-01), to the U.S. market to address drug shortage. Currently this product is unavailable to order. Once it is available again, please contact ANDA at1-855-336-3322, Option # 9. There is a side by side comparison between Aristospan and Hexatrione available at https://www.fda.gov/media/154709/download.
Updated
Updated April 6, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 22, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.